efavirenz sandoz 600mg film-coated tablets
1 a pharma gmbh - efavirenz 600 mg - film-coated tablet
efavirenz teva
teva b.v. - efavirenz - hiv infections - antivirals for systemic use - efavirenz is indicated in antiviral combination treatment of human-immunodeficiency-virus-1 (hiv-1)-infected adults, adolescents and children 3 years of age and older.efavirenz has not been adequately studied in patients with advanced hiv disease, namely in patients with cd4 counts < 50 cells/mm3, or after failure of protease inhibitor (pi)-containing regimens. although cross-resistance of efavirenz with protease inhibitors (pis) has not been documented, there are at present insufficient data on the efficacy of subsequent use of pi-based combination therapy after failure of regimens containing efavirenz.
efavirenz 600mg tablets
mylan - efavirenz - tablet - 600mg
efavirenz sandoz 600mg film-coated tablets
sandoz pharmaceuticals d.d. verovškova ulica 57, si-1000 ljubljana, slovenia - efavirenz - film-coated tablet - efavirenz 600 mg - antivirals for systemic use
afinitor
novartis pharmaceuticals australia pty ltd - everolimus -
aropax
aspen pharmacare australia pty ltd - paroxetine hydrochloride hemihydrate -
atorvastatin pfizer
pfizer australia pty ltd - atorvastatin calcium -
cadatin
pfizer australia pty ltd - amlodipine besylate; atorvastatin calcium -
caduet
pfizer australia pty ltd - amlodipine besylate; atorvastatin calcium -
chemmart paroxetine
apotex pty ltd - paroxetine hydrochloride -